Published in Neuroendocrinology on October 01, 1987
High concentrations of catecholamines in human hypothalamic-hypophysial blood. J Clin Invest (1989) 0.75
Spermine and spermidine as gating molecules for inward rectifier K+ channels. Science (1994) 4.82
Exchange of conduction pathways between two related K+ channels. Science (1991) 3.09
Guidelines for acromegaly management: an update. J Clin Endocrinol Metab (2009) 2.96
Gating of inwardly rectifying K+ channels localized to a single negatively charged residue. Nature (1994) 2.91
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Inactivation determined by a single site in K+ pores. Pflugers Arch (1993) 2.37
Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis (2002) 2.24
Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial. J Clin Endocrinol Metab (2010) 2.16
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab (1997) 2.14
Impairment of GH secretion in adults with primary empty sella. J Endocrinol Invest (2002) 2.09
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? Osteoporos Int (2013) 2.00
Spinal metastases with neurological manifestations. Review of 600 cases. J Neurosurg (1983) 1.76
Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death. Mol Pharmacol (2007) 1.71
Differences between the deep pores of K+ channels determined by an interacting pair of nonpolar amino acids. Neuron (1992) 1.69
Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab (1998) 1.58
herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res (1998) 1.57
Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocortical adenoma. Eur J Endocrinol (1995) 1.56
A single nonpolar residue in the deep pore of related K+ channels acts as a K+:Rb+ conductance switch. Biophys J (1992) 1.54
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Dig Liver Dis (2001) 1.46
Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Clin Endocrinol (Oxf) (2009) 1.46
Spinal deformity index in patients with type 2 diabetes. Endocrine (2012) 1.45
Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans. Eur Heart J (1997) 1.43
H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy (2002) 1.41
CV 205-502 treatment in therapy-resistant acromegalic patients. Eur J Endocrinol (1995) 1.40
The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clin Endocrinol (Oxf) (2000) 1.40
[Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus]. Minerva Med (1992) 1.39
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. Eur J Endocrinol (1996) 1.39
ACROSTUDY: the Italian experience. Endocrine (2014) 1.38
Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures. Minim Invasive Neurosurg (2002) 1.35
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology (2004) 1.33
Involvement of D-aspartic acid in the synthesis of testosterone in rat testes. Life Sci (1996) 1.28
Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol (Oxf) (1997) 1.25
Primary empty sella: Why and when to investigate hypothalamic-pituitary function. J Endocrinol Invest (2010) 1.21
Cloning and functional expression of an inwardly rectifying K+ channel from human atrium. Circ Res (1995) 1.17
Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab (2006) 1.17
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. Eur J Endocrinol (2008) 1.14
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Invest (2008) 1.14
Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome. J Mol Cell Cardiol (2000) 1.13
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study. Hum Reprod (2007) 1.10
Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. J Biol Chem (2001) 1.10
Regulation of the human ether-a-gogo related gene (HERG) K+ channels by reactive oxygen species. Proc Natl Acad Sci U S A (1997) 1.09
Treatment of trigeminal neuralgia by ophthalmic anesthetic. J Neurosurg (1992) 1.09
HIF-1alpha reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. J Neurochem (2004) 1.07
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metab (2000) 1.07
Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab (1993) 1.07
Gross hematuria of uncommon origin: the nutcracker syndrome. Am J Kidney Dis (1998) 1.06
Do glia have heart? Expression and functional role for ether-a-go-go currents in hippocampal astrocytes. J Neurosci (2000) 1.05
Regulation by spermine of native inward rectifier K+ channels in RBL-1 cells. J Biol Chem (1996) 1.03
Characterization of a human and murine gene (CLCN3) sharing similarities to voltage-gated chloride channels and to a yeast integral membrane protein. Genomics (1995) 1.02
Internal and external TEA block in single cloned K+ channels. Am J Physiol (1991) 1.01
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med (2006) 1.01
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Metab (2001) 1.01
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines. Mol Pharmacol (1998) 1.00
Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg). J Clin Endocrinol Metab (2000) 0.98
Posterior fossa hemangioblastomas. Surg Neurol (1986) 0.98
Benign intrasellar cysts. Surg Neurol (1981) 0.98
Protein-tyrosine kinases activate while protein-tyrosine phosphatases inhibit L-type calcium channel activity in pituitary GH3 cells. J Biol Chem (1996) 0.97
Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol (2001) 0.97
Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. J Clin Endocrinol Metab (2000) 0.96
Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol (2012) 0.96
Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. Bone Marrow Transplant (2006) 0.96
Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus. J Clin Endocrinol Metab (2002) 0.96
Cabergoline. Expert Opin Pharmacother (2000) 0.96
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly. J Endocrinol Invest (2009) 0.95
Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab (1997) 0.95
The molecular causes of thyroid dysgenesis: a systematic review. J Endocrinol Invest (2013) 0.95
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. J Endocrinol Invest (2011) 0.95
Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. Br J Clin Pharmacol (1983) 0.95
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab (2012) 0.95
Differential vulnerability of cortical and cerebellar neurons in primary culture to oxygen glucose deprivation followed by reoxygenation. J Neurosci Res (2001) 0.94
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes. Neurology (2003) 0.94
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. J Endocrinol Invest (2011) 0.94
Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations. Clin Exp Allergy (2003) 0.94
Cardiovascular complications in acromegaly. Minerva Endocrinol (2004) 0.94
Acromegaly. J Clin Endocrinol Metab (1997) 0.93
Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications. Biochem Pharmacol (1998) 0.92
Sentinel lymph node biopsy in squamous cell carcinoma of the head and neck: 10 years of experience. Acta Otorhinolaryngol Ital (2012) 0.92
NGF withdrawal induces apoptosis in CESS B cell line through p38 MAPK activation and Bcl-2 phosphorylation. Biochem Biophys Res Commun (2000) 0.92
[Usefulness of color echo Doppler with power Doppler in the diagnosis of hypoechoic thyroid nodules: work in progress]. Radiol Med (1996) 0.92
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study. J Cell Mol Med (2012) 0.92
Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults. J Endocrinol Invest (2008) 0.92
Hemangioma of the temporal muscle. Head Neck (1996) 0.91
Selective arterial embolisation in aneurysmal bone cysts. Int Orthop (1982) 0.91
Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med (1997) 0.91
New insights into the second generation antihistamines. Drugs (2001) 0.91
Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. J Biol Regul Homeost Agents (2011) 0.91
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers. J Endocrinol Invest (2008) 0.91